Formulations

We understand that speed is of the essence when working to deliver a life-changing drug to market. Our experienced clinical formulation development team can support formulation development across a vast range of dosage forms - including oral, ophthalmic and transdermal formulations, as well as injectables, inhaled therapies and more. Whether NCE or 505(b)(2), we can work with our partners to help you rapidly progress your drug from the preclinical stage through to commercial formulation development as part of an integrated process. Benefits of formulation development with Nanoform Our rigorous QbD approach to the formulation development of nanoformed drugs can open up new possibilities for drug delivery innovation. Reducing the API's size down to the nanoscale can enable: Reproducibly fast dissolution High drug load Potential for a simple formulation with less excipients High physical suspension stability Enhanced permeability Novel opportunities for exploring coformulations, in particular dual API formulations